HOME >> BIOLOGY >> NEWS
Reconstructed 1918 flu virus providing insights for potential pandemics

For the first time, this deadly 1918 Spanish flue virus has been reconstructed and characterized. This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine. Their goal is to gain a greater understanding of this virus in order to use this knowledge to predict future pandemics and develop novel vaccines and treatments.

Drs. Garcia-Sastre and Palese and Christopher Basler, PhD, Assistant Professor of Microbiology worked with colleagues at the Centers for Disease Control, the Armed Forces Institute of Pathology in Maryland and The United States Department of Agriculture to characterize the 1918 virus. The reconstructed virus is contained at the CDC, following stringent safety conditions designated for flu viruses and other "select agents."

The virus was reconstructed using reverse genetics, a technique Drs. Garcia-Sastre and Palese developed. (See below for a description of the reverse genetics technique, which is being widely used in research to develop vaccines for a potential pandemic.)

The emergence of another pandemic is considered highly likely by many experts, but it is currently not possible to predict which viruses will become pandemics or how virulent a pandemic virus will be. Understanding the Spanish flu, the most virulent and deadly pandemic in recent history, may provide the information needed to anticipate which flu viruses have the potential to cause pandemics, determine in advance how virulent the virus is, and develop vaccines and treatments to prevent the potential devastation of a pandemic.

Three major discoveries about the virulence of the 1918 virus are included in the Science report:

  • 1) It is extremely virulent in mice, leading to rapid death.
  • 2) It is pathogenic in embryonated chicken eggs

  • '"/>


Contact: Debra Kaplan
debra.kaplan@mssm.edu
212-659-9045
The Mount Sinai Hospital / Mount Sinai School of Medicine
5-Oct-2005


Page: 1 2 3

Related biology news :

1. Reconstructed 1918 influenza virus induces immune response that fails to protect
2. Features of replication suggest viruses have common themes, vulnerabilities
3. Marijuana component opens the door for virus that causes Kaposis sarcoma
4. Discovery in plant virus may help prevent HIV and similar viruses
5. Detecting transmissibility of avian influenza virus in human households
6. CTRC enrolls first patients in novel phase II study for sarcoma -- living virus destroys cancer cell
7. Expert to provide update after worst tomato virus hits California
8. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
9. Modified herpes virus keeps arteries free-flowing following procedures
10. MIT, BU team builds viruses to combat harmful biofilms
11. First all-African produced genetically engineered maize is resistant to maize streak virus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... 12, 2020 , ... Mosio recently announced its newly updated ... agencies of all sizes. With a focus on tracking symptoms and monitoring outbreaks ... care, Mosio helps public health departments automate communications and provide more personalized care ...
(Date:7/31/2020)... Md. (PRWEB) , ... July 30, 2020 , ... ... Innovation Research (SBIR) Phase II contract awarded by the Joint Science & Technology ... of this project is to develop, optimize, and scale-up a highly efficient mammalian ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... up to three different materials for use with CRM, neurostimulation, vascular, and related ... materials to meet specific design requirements, performance, and cost criteria; especially where solid ...
(Date:7/31/2020)... ... 2020 , ... eSource has long been touted as the solution to high ... eSource, the reasons it did not take off as quickly as people initially expected, ... is moving towards capturing data electronically for clinical trials and then repurposing it for ...
Breaking Biology Technology:
Cached News: